|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deplanque G and Demartines N: Pancreatic
cancer: Are more chemotherapy and surgery needed? Lancet.
389:985–986. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Théry C: Exosomes: Secreted vesicles and
intercellular communications. F1000 Biol Rep. 3:152011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalluri R: The biology and function of
exosomes in cancer. J Clin Invest. 126:1208–1215. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vader P, Breakefield XO and Wood MJ:
Extracellular vesicles: Emerging targets for cancer therapy. Trends
Mol Med. 20:385–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Skog J, Wurdinger T, van Rijn S, Meijer
DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky
AM and Breakefield XO: Glioblastoma microvesicles transport RNA and
proteins that promote tumour growth and provide diagnostic
biomarkers. Nat Cell Biol. 10:1470–1476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Johnstone RM, Adam M, Hammond JR, Orr L
and Turbide C: Vesicle formation during reticulocyte maturation.
Association of plasma membrane activities with released vesicles
(exosomes). J Biol Chem. 262:9412–9420. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kowal J, Tkach M and Théry C: Biogenesis
and secretion of exosomes. Curr Opin Cell Biol. 29:116–125. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meehan K and Vella LJ: The contribution of
tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin
Lab Sci. 53:121–131. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fong MY, Zhou W, Liu L, Alontaga AY,
Chandra M, Ashby J, Chow A, O'Connor STF, Li S, Chin AR, et al:
Breast-cancer-secreted miR-122 reprograms glucose metabolism in
premetastatic niche to promote metastasis. Nat Cell Biol.
17:183–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mu W, Rana S and Zöller M: Host matrix
modulation by tumor exosomes promotes motility and invasiveness.
Neoplasia. 15:875–887. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sung BH, Ketova T, Hoshino D, Zijlstra A
and Weaver AM: Directional cell movement through tissues is
controlled by exosome secretion. Nat Commun. 6:71642015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zitvogel L, Regnault A, Lozier A, Wolfers
J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G and
Amigorena S: Eradication of established murine tumors using a novel
cell-free vaccine: Dendritic cell-derived exosomes. Nat Med.
4:594–600. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim
TE, Chin JL and Min WP: Tumor exosomes expressing Fas ligand
mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis.
35:169–173. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kamerkar S, LeBleu VS, Sugimoto H, Yang S,
Ruivo CF, Melo SA, Lee JJ and Kalluri R: Exosomes facilitate
therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Nature. 546:498–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bobrie A, Krumeich S, Reyal F, Recchi C,
Moita LF, Seabra MC, Ostrowski M and Théry C: Rab27a supports
exosome-dependent and -independent mechanisms that modify the tumor
microenvironment and can promote tumor progression. Cancer Res.
72:4920–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhatia A and Kumar Y: Cellular and
molecular mechanisms in cancer immune escape: A comprehensive
review. Expert Rev Clin Immunol. 10:41–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mateescu B, Kowal EJ, van Balkom BW,
Bartel S, Bhattacharyya SN, Buzás EI, Buck AH, de Candia P, Chow
FWN, Das S, et al: Obstacles and opportunities in the functional
analysis of extracellular vesicle RNA-an ISEV position paper. J
Extracell Vesicles. 6:12860952017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Colombo M, Raposo G and Théry C:
Biogenesis, secretion, and intercellular interactions of exosomes
and other extracellular vesicles. Annu Rev Cell Dev Biol.
30:255–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang HG and Grizzle WE: Exosomes: A novel
pathway of local and distant intercellular communication that
facilitates the growth and metastasis of neoplastic lesions. Am J
Pathol. 184:28–41. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong CS, Funk S and Whiteside TL:
Isolation of biologically active exosomes from plasma of patients
with cancer. Methods Mol Biol. 1633:257–265. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xie JX, Fan X, Drummond CA, Majumder R,
Xie Y, Chen T, Liu L, Haller ST, Brewster PS, Dworkin LD, et al:
MicroRNA profiling in kidney disease: Plasma versus plasma-derived
exosomes. Gene. 627:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou X, Lu Z, Wang T, Huang Z, Zhu W and
Miao Y: Plasma miRNAs in diagnosis and prognosis of pancreatic
cancer: A miRNA expression analysis. Gene. 673:181–193. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW and Zöller
M: Combined evaluation of a panel of protein and miRNA
serum-exosome biomarkers for pancreatic cancer diagnosis increases
sensitivity and specificity. Int J Cancer. 136:2616–2627. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Street JM, Koritzinsky EH, Glispie DM,
Star RA and Yuen PST: Urine exosomes: An emerging trove of
biomarkers. Adv Clin Chem. 78:103–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Katsiougiannis S, Chia D, Kim Y, Singh RP
and Wong DTW: Saliva exosomes from pancreatic tumor-bearing mice
modulate NK cell phenotype and antitumor cytotoxicity. FASEB J.
31:998–1010. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Y, Liu S, Qiao Z, Shang Z, Xia Z, Niu
X, Qian L, Zhang Y, Fan L, Cao CX and Xiao H: Systematic comparison
of exosomal proteomes from human saliva and serum for the detection
of lung cancer. Anal Chim Acta. 982:84–95. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qin W, Tsukasaki Y, Dasgupta S,
Mukhopadhyay N, Ikebe M and Sauter ER: Exosomes in human breast
milk promote EMT. Clin Cancer Res. 22:4517–4524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mathivanan S, Ji H and Simpson RJ:
Exosomes: Extracellular organelles important in intercellular
communication. J Proteomics. 73:1907–1920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
van Niel G, Porto-Carreiro I, Simoes S and
Raposo G: Exosomes: A common pathway for a specialized function. J
Biochem. 140:13–21. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nazarenko I, Rana S, Baumann A, McAlear J,
Hellwig A, Trendelenburg M, Lochnit G, Preissner KT and Zöller M:
Cell surface tetraspanin Tspan8 contributes to molecular pathways
of exosome-induced endothelial cell activation. Cancer Res.
70:1668–1678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Raimondo F, Morosi L, Chinello C, Magni F
and Pitto M: Advances in membranous vesicle and exosome proteomics
improving biological understanding and biomarker discovery.
Proteomics. 11:709–720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Runz S, Keller S, Rupp C, Stoeck A, Issa
Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G and Altevogt P:
Malignant ascites-derived exosomes of ovarian carcinoma patients
contain CD24 and EpCAM. Gynecol Oncol. 107:563–571. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Salido-Guadarrama I, Romero-Cordoba S,
Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M:
MicroRNAs transported by exosomes in body fluids as mediators of
intercellular communication in cancer. OncoTargets Ther.
7:1327–1338. 2014.
|
|
40
|
Medina PP, Nolde M and Slack FJ: OncomiR
addiction in an in vivo model of microRNA-21-induced pre-B-cell
lymphoma. Nature. 467:86–90. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schutters K and Reutelingsperger C:
Phosphatidylserine targeting for diagnosis and treatment of human
diseases. Apoptosis. 15:1072–1082. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Beloribi S, Ristorcelli E, Breuzard G,
Silvy F, Bertrand-Michel J, Beraud E, Verine A and Lombardo D:
Exosomal lipids impact notch signaling and induce death of human
pancreatic tumoral SOJ-6 cells. PLoS One. 7:e474802012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Beloribi-Djefaflia S, Siret C and Lombardo
D: Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells
resistance through the CXCR4-SDF-1α signaling axis. Oncoscience.
2:15–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y, Yang J, Li H, Wu Y, Zhang H and
Chen W: Tumor markers CA19-9, CA242 and CEA in the diagnosis of
pancreatic cancer: A meta-analysis. Int J Clin Exp Med.
8:11683–11691. 2015.PubMed/NCBI
|
|
45
|
Frebourg T, Bercoff E, Manchon N, Senant
J, Basuyau JP, Breton P, Janvresse A, Brunelle P and Bourreille J:
The evaluation of CA 19-9 antigen level in the early detection of
pancreatic cancer. A prospective study of 866 patients. Cancer.
62:2287–2290. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Awad W, Adamczyk B, Ornros J, Karlsson NG,
Mani K and Logan DT: Structural aspects of N-glycosylations and the
C-terminal region in human glypican-1. J Biol Chem.
290:22991–23008. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Aikawa T, Whipple CA, Lopez ME, Gunn J,
Young A, Lander AD and Korc M: Glypican-1 modulates the angiogenic
and metastatic potential of human and mouse cancer cells. J Clin
Invest. 118:89–99. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Frampton AE, Prado MM, Lopez-Jimenez E,
Fajardo-Puerta AB, Jawad ZAR, Lawton P, Giovannetti E, Habib NA,
Castellano L, Stebbing J, et al: Glypican-1 is enriched in
circulating-exosomes in pancreatic cancer and correlates with tumor
burden. Oncotarget. 9:19006–19013. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Joshi GK, Deitz-McElyea S, Liyanage T,
Lawrence K, Mali S, Sardar R and Korc M: Label-Free
nanoplasmonic-based short noncoding RNA sensing at attomolar
concentrations allows for quantitative and highly specific assay of
MicroRNA-10b in biological fluids and circulating exosomes. ACS
Nano. 9:11075–11089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Taller D, Richards K, Slouka Z, Senapati
S, Hill R, Go DB and Chang HC: On-chip surface acoustic wave lysis
and ion-exchange nanomembrane detection of exosomal RNA for
pancreatic cancer study and diagnosis. Lab Chip. 15:1656–1666.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu YF, Hannafon BN, Zhao YD, Postier RG
and Ding WQ: Plasma exosome miR-196a and miR-1246 are potential
indicators of localized pancreatic cancer. Oncotarget.
8:77028–77040. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Takahasi K, Iinuma H, Wada K, Minezaki S,
Kawamura S, Kainuma M, Ikeda Y, Shibuya M, Miura F and Sano K:
Usefulness of exosome-encapsulated microRNA-451a as a minimally
invasive biomarker for prediction of recurrence and prognosis in
pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci.
25:155–161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Que R, Ding G, Chen J and Cao L: Analysis
of serum exosomal microRNAs and clinicopathologic features of
patients with pancreatic adenocarcinoma. World J Surg Oncol.
11:2192013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yan Y, Fu G and Ming L: Role of exosomes
in pancreatic cancer. Oncol Lett. 15:7479–7488. 2018.PubMed/NCBI
|
|
55
|
Machida T, Tomofuji T, Maruyama T, Yoneda
T, Ekuni D, Azuma T, Miyai H, Mizuno H, Kato H, Tsutsumi K, et al:
miR1246 and miR4644 in salivary exosome as potential biomarkers for
pancreatobiliary tract cancer. Oncol Rep. 36:2375–2381. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Biol. 17:816–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tsukamoto M, Iinuma H, Yagi T, Matsuda K
and Hashiguchi Y: Circulating exosomal MicroRNA-21 as a biomarker
in each tumor stage of colorectal cancer. Oncology. 92:360–370.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kahlert C, Melo SA, Protopopov A, Tang J,
Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A and Kalluri R:
Identification of double-stranded genomic DNA spanning all
chromosomes with mutated KRAS and p53 DNA in the serum exosomes of
patients with pancreatic cancer. J Biol Chem. 289:3869–3875. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sessa F, Bonato M, Bisoni D, Ranzani GN
and Capella C: Ki-ras and p53 gene mutations in pancreatic ductal
carcinoma: A relationship with tumor phenotype and survival. Eur J
Histochem. 42:Spec No. 67–76. 1998.PubMed/NCBI
|
|
60
|
Charrier A, Chen R, Chen L, Kemper S,
Hattori T, Takigawa M and Brigstock DR: Connective tissue growth
factor (CCN2) and microRNA-21 are components of a positive feedback
loop in pancreatic stellate cells (PSC) during chronic pancreatitis
and are exported in PSC-derived exosomes. J Cell Commun Signal.
8:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pang W, Su J, Wang Y, Feng H, Dai X, Yuan
Y, Chen X and Yao W: Pancreatic cancer-secreted miR-155 implicates
in the conversion from normal fibroblasts to cancer-associated
fibroblasts. Cancer Sci. 106:1362–1369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
von Ahrens D, Bhagat TD, Nagrath D, Maitra
A and Verma A: The role of stromal cancer-associated fibroblasts in
pancreatic cancer. J Hematol Oncol. 10:762017. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Wu DM, Wen X, Han XR, Wang S, Wang YJ,
Shen M, Fan SH, Zhang ZF, Shan Q, Li MQ, et al: Bone marrow
mesenchymal stem cell-derived exosomal MicroRNA-126-3p inhibits
pancreatic cancer development by targeting ADAM9. Mol Ther Nucleic
Acids. 16:229–245. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang J, Zhang Z, Zhang Y, Ni X, Zhang G,
Cui X, Liu M, Xu C, Zhang Q, Zhu H, et al: ZIP4 promotes muscle
wasting and cachexia in mice with orthotopic pancreatic tumors by
stimulating RAB27B-regulated release of extracellular vesicles from
cancer cells. Gastroenterology. 156:722–734. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yu Z, Zhao S, Ren L, Wang L, Chen Z,
Hoffman RM and Zhou J: Pancreatic cancer-derived exosomes promote
tumor metastasis and liver pre-metastatic niche formation.
Oncotarget. 8:63461–63483. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Sceneay J, Smyth MJ and Möller A: The
pre-metastatic niche: Finding common ground. Cancer Metastasis Rev.
32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Nielsen SR, Quaranta V, Linford A, Emeagi
P, Rainer C, Santos A, Ireland L, Sakai T, Sakai K, Kim YS, et al:
Macrophage-secreted granulin supports pancreatic cancer metastasis
by inducing liver fibrosis. Nat Cell Biol. 18:549–560. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Dey A, Allen J and Hankey-Giblin PA:
Ontogeny and polarization of macrophages in inflammation: Blood
monocytes versus tissue macrophages. Front Immunol. 5:6832015.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Matsushita H, Yang YM, Pandol SJ and Seki
E: Exosome migration inhibitory factor as a marker and therapeutic
target for pancreatic cancer. Gastroenterology. 150:1033–1035.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Syn N, Wang L, Sethi G, Thiery JP and Goh
BC: Exosome-mediated metastasis: From epithelial-mesenchymal
transition to escape from immunosurveillance. Trends Pharmacol Sci.
37:606–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Steinbichler TB, Dudás J, Riechelmann H
and Skvortsova II: The role of exosomes in cancer metastasis. Semin
Cancer Biol. 44:170–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ackerman D and Simon MC: Hypoxia, lipids,
and cancer: Surviving the harsh tumor microenvironment. Trends Cell
Biol. 24:472–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
King HW, Michael MZ and Gleadle JM:
Hypoxic enhancement of exosome release by breast cancer cells. BMC
Cancer. 12:4212012. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Löfstedt T, Fredlund E,
Holmquist-Mengelbier L, Pietras A, Ovenberger M, Poellinger L and
Påhlman S: Hypoxia inducible factor-2alpha in cancer. Cell Cycle.
6:919–926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Singh A, Talekar M, Raikar A and Amiji M:
Macrophage-targeted delivery systems for nucleic acid therapy of
inflammatory diseases. J Control Release. 190:515–530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Wang J, Cao Z, Zhang XM, Nakamura M, Sun
M, Hartman J, Harris RA, Sun Y and Cao Y: Novel mechanism of
macrophage-mediated metastasis revealed in a zebrafish model of
tumor development. Cancer Res. 75:306–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang X, Luo G, Zhang K, Cao J, Huang C,
Jiang T, Liu B, Su L and Qiu Z: Hypoxic tumor-derived exosomal
miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to
promote pancreatic cancer metastasis. Cancer Res. 78:4586–4598.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li Z, Yanfang W, Li J, Jiang P, Peng T,
Chen K, Zhao X, Zhang Y, Zhen P, Zhu J and Li X: Tumor-released
exosomal circular RNA PDE8A promotes invasive growth via the
miR-338/MACC1/MET pathway in pancreatic cancer. Cancer Lett.
432:237–250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Takikawa T, Masamune A, Yoshida N, Hamada
S, Kogure T and Shimosegawa T: Exosomes derived from pancreatic
stellate cells: MicroRNA signature and effects on pancreatic cancer
cells. Pancreas. 46:19–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Chen D, Wu X, Xia M, Wu F, Ding J, Jiao Y,
Zhan Q and An F: Upregulated exosomic miR-23b-3p plays regulatory
roles in the progression of pancreatic cancer. Oncol Rep.
38:2182–2188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kurahara H, Shinchi H, Mataki Y, Maemura
K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S and Takao S:
Significance of M2-polarized tumor-associated macrophage in
pancreatic cancer. J Surg Res. 167:e211–e219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Di Caro G, Cortese N, Castino GF, Grizzi
F, Gavazzi F, Ridolfi C, Capretti G, Mineri R, Todoric J, Zerbi A,
et al: Dual prognostic significance of tumour-associated
macrophages in human pancreatic adenocarcinoma treated or untreated
with chemotherapy. Gut. 65:1710–1720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Szczepanski MJ, Szajnik M, Welsh A,
Whiteside TL and Boyiadzis M: Blast-derived microvesicles in sera
from patients with acute myeloid leukemia suppress natural killer
cell function via membrane-associated transforming growth
factor-beta1. Haematologica. 96:1302–1309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Fridlender ZG, Sun J, Kim S, Kapoor V,
Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of
tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’
TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Benson DD, Meng X, Fullerton DA, Moore EE,
Lee JH, Ao L, Silliman CC and Barnett CC Jr: Activation state of
stromal inflammatory cells in murine metastatic pancreatic
adenocarcinoma. Am J Physiol Regul Integr Comp Physiol.
302:R1067–R1075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Galdiero MR, Bonavita E, Barajon I,
Garlanda C, Mantovani A and Jaillon S: Tumor associated macrophages
and neutrophils in cancer. Immunobiology. 218:1402–1410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki
M, Kosuge T, Kanai Y and Hiraoka N: Immune cell infiltration as an
indicator of the immune microenvironment of pancreatic cancer. Br J
Cancer. 108:914–923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Hiraoka N, Onozato K, Kosuge T and
Hirohashi S: Prevalence of FOXP3+ regulatory T cells increases
during the progression of pancreatic ductal adenocarcinoma and its
premalignant lesions. Clin Cancer Res. 12:5423–5434. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Szajnik M, Czystowska M, Szczepanski MJ,
Mandapathil M and Whiteside TL: Tumor-derived microvesicles induce,
expand and up-regulate biological activities of human regulatory T
cells (Treg). PLoS One. 5:e114692010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Wada J, Onishi H, Suzuki H, Yamasaki A,
Nagai S, Morisaki T and Katano M: Surface-bound TGF-beta1 on
effusion-derived exosomes participates in maintenance of number and
suppressive function of regulatory T-cells in malignant effusions.
Anticancer Res. 30:3747–3757. 2010.PubMed/NCBI
|
|
96
|
Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen
J, Xiang J, Wu Z, Jiang G and Cao L: Pancreatic cancer-derived
exosomes transfer miRNAs to dendritic cells and inhibit RFXAP
expression via miR-212-3p. Oncotarget. 6:29877–29888. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhou M, Chen J, Zhou L, Chen W, Ding G and
Cao L: Pancreatic cancer derived exosomes regulate the expression
of TLR4 in dendritic cells via miR-203. Cell Immunol. 292:65–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Nagathihalli NS, Castellanos JA, Shi C,
Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC,
Moses HL and Merchant NB: Signal transducer and activator of
transcription 3, mediated remodeling of the tumor microenvironment
results in enhanced tumor drug delivery in a mouse model of
pancreatic cancer. Gastroenterology. 149:1932–1943, e1939. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lobb RJ, van Amerongen R, Wiegmans A, Ham
S, Larsen JE and Möller A: Exosomes derived from mesenchymal
non-small cell lung cancer cells promote chemoresistance. Int J
Cancer. 141:614–620. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Santos JC, da Silva Lima N, Sarian LO,
Matheu A, Ribeiro ML and Derchain SFM: Exosome-mediated breast
cancer chemoresistance via miR-155 transfer. Sci Rep. 8:8292018.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Li J, Yang X, Guan H, Mizokami A, Keller
ET, Xu X, Liu X, Tan J, Hu L, Lu Y and Zhang J: Exosome-derived
microRNAs contribute to prostate cancer chemoresistance. Int J
Oncol. 49:838–846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Wang M, Qiu R, Yu S, Xu X, Li G, Gu R, Tan
C, Zhu W and Shen B: Paclitaxelresistant gastric cancer MGC803
cells promote epithelialtomesenchymal transition and
chemoresistance in paclitaxelsensitive cells via exosomal delivery
of miR1555p. Int J Oncol. 54:326–338. 2019.PubMed/NCBI
|
|
104
|
Marques-Rocha JL, Garcia-Lacarte M,
Samblas M, Bressan J, Martínez JA and Milagro FI: Regulatory roles
of miR-155 and let-7b on the expression of inflammation-related
genes in THP-1 cells: Effects of fatty acids. J Physiol Biochem.
74:579–589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Patel GK, Khan MA, Bhardwaj A, Srivastava
SK, Zubair H, Patton MC, Singh S, Khushman M and Singh AP: Exosomes
confer chemoresistance to pancreatic cancer cells by promoting ROS
detoxification and miR-155-mediated suppression of key
gemcitabine-metabolising enzyme, DCK. Br J Cancer. 116:609–619.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Mikamori M, Yamada D, Eguchi H, Hasegawa
S, Kishimoto T, Tomimaru Y, Asaoka T, Noda T, Wada H, Kawamoto K,
et al: MicroRNA-155 controls exosome synthesis and promotes
gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci
Rep. 7:423392017. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Asuncion Valenzuela MM, Castro I, Gonda A,
Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW and Wall
NR: Cell death in response to antimetabolites directed at
ribonucleotide reductase and thymidylate synthase. Onco Targets
Ther. 8:495–507. 2015.PubMed/NCBI
|
|
108
|
Fan J, Wei Q, Koay EJ, Liu Y, Ning B,
Bernard PW, Zhang N, Han H, Katz MH, Zhao Z and Hu Y:
Chemoresistance transmission via exosome-mediated EphA2 transfer in
pancreatic cancer. Theranostics. 8:5986–5994. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
van den Boorn JG, Schlee M, Coch C and
Hartmann G: SiRNA delivery with exosome nanoparticles. Nat
Biotechnol. 29:325–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Buscail L: Pancreatic cancer: Exosomes for
targeting KRAS in the treatment of pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 14:636–638. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Christianson HC, Svensson KJ, van
Kuppevelt TH, Li JP and Belting M: Cancer cell exosomes depend on
cell-surface heparan sulfate proteoglycans for their
internalization and functional activity. Proc Natl Acad Sci USA.
110:17380–17385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Fares J, Kashyap R and Zimmermann P:
Syntenin: Key player in cancer exosome biogenesis and uptake? Cell
Adh Migr. 11:124–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Pascucci L, Cocce V, Bonomi A, Ami D,
Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia AM,
et al: Paclitaxel is incorporated by mesenchymal stromal cells and
released in exosomes that inhibit in vitro tumor growth: A new
approach for drug delivery. J Control Release. 192:262–270. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Kim MS, Haney MJ, Zhao Y, Mahajan V,
Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O,
et al: Development of exosome-encapsulated paclitaxel to overcome
MDR in cancer cells. Nanomedicine. 12:655–664. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Oldrini B, Vaquero-Siguero N, Mu Q, Kroon
P, Zhang Y, Galán-Ganga M, Bao Z, Wang Z, Liu H, Sa JK, et al: MGMT
genomic rearrangements contribute to chemotherapy resistance in
gliomas. Nat Commun. 11:38832020. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Xu L, Faruqu FN, Liam-Or R, Abed OA, Li D,
Venner K, Errington RJ, Summers H, Wang JTW and Al-Jamal KT: Design
of experiment (DoE)-driven in vitro and in vivo uptake studies of
exosomes for pancreatic cancer delivery enabled by copper-free
click chemistry-based labelling. J Extracell Vesicles.
9:17794582020. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Zhou Y, Zhou G, Tian C, Jiang W, Jin L,
Zhang C and Chen X: Exosome-mediated small RNA delivery for gene
therapy. Wiley Interdiscip Rev RNA. 7:758–771. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Papandreou ME and Tavernarakis N:
Autophagy and the endo/exosomal pathways in health and disease.
Biotechnol J. 12:2017. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Pan JH, Zhou H, Zhao XX, Ding H, Li W, Qin
L and Pan YL: Role of exosomes and exosomal microRNAs in
hepatocellular carcinoma: Potential in diagnosis and antitumour
treatments (Review). Int J Mol Med. 41:1809–1816. 2018.PubMed/NCBI
|
|
120
|
Zhang Y, Liu YT, Tang H, Xie WQ, Yao H, Gu
WT, Zheng YZ, Shang HB, Wang Y, Wei YX, et al: Exosome-transmitted
lncRNA H19 inhibits the growth of pituitary adenoma. J Clin
Endocrinol Metab. 104:6345–6356. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Zhao X, Ren Y, Cui N, Wang X and Cui Y:
Identification of key microRNAs and their targets in exosomes of
pancreatic cancer using bioinformatics analysis. Medicine
(Baltimore). 97:e126322018. View Article : Google Scholar : PubMed/NCBI
|
